Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects
- 20 October 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (24) , 4389-4393
- https://doi.org/10.1016/j.bmcl.2003.09.024
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chain-Branched acyclic phenethylthiocarbamates as vanilloid receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2003
- Synthesis of N,N′,N″-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptorBioorganic & Medicinal Chemistry Letters, 2003
- Synthesis of 2-substituted-pyrrolidinethiourea derivatives and their antagonist effect on vanilloid receptorBioorganic & Medicinal Chemistry Letters, 2002
- High Affinity Antagonists of the Vanilloid ReceptorMolecular Pharmacology, 2002
- Iodo-Resiniferatoxin, a New Potent Vanilloid Receptor AntagonistMolecular Pharmacology, 2001
- Arginine‐rich peptides are blockers of VR‐1 channels with analgesic activityFEBS Letters, 2000
- Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substancesProceedings of the National Academy of Sciences, 2000
- Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesiaNature, 2000
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 2000
- The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing StimuliNeuron, 1998